Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
---|---|---|---|---|---|---|---|
LUMOS PHARMA, INC. | General Counsel | Common Stock | 6.31K | $17.9K | $2.84 | Apr 1, 2024 | Direct |
LUMOS PHARMA, INC. | General Counsel | Common Stock | 27 | $74.90 | $2.78 | Apr 1, 2024 | By Spouse |
LUMOS PHARMA, INC. | General Counsel | Stock Option (Right to Buy) | 11K | Apr 1, 2024 | Direct |
Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
---|---|---|---|---|---|---|---|
(LUMO) | LUMOS PHARMA, INC. | Apr 1, 2024 | 3 | $1.58K | 4 | Apr 3, 2024 | General Counsel |
(LUMO) | LUMOS PHARMA, INC. | Feb 1, 2024 | 1 | -$722 | 4 | Feb 5, 2024 | General Counsel |
LUMO | LUMOS PHARMA, INC. | Apr 1, 2023 | 1 | -$1.13K | 4 | Apr 4, 2023 | General Counsel |
LUMO | LUMOS PHARMA, INC. | Feb 1, 2023 | 3 | $2.71K | 4 | Feb 3, 2023 | General Counsel |
LUMO | LUMOS PHARMA, INC. | Apr 1, 2022 | 1 | -$3.16K | 4 | Apr 5, 2022 | General Counsel |
LUMO | LUMOS PHARMA, INC. | Feb 1, 2022 | 3 | $8.24K | 4 | Feb 3, 2022 | General Counsel |